Is a PCSK9 Inhibitor Right for Your Patient? A Review of Treatment Data for Individualized Therapy.

Roman A Beltran, Kyle J Zemeir, Chase R Kimberling, Mary S Kneer, Michelle D Mifflin,Tom L Broderick

International journal of environmental research and public health（2022）

引用 0|浏览0

暂无评分

摘要

There are many statin-alternative therapies that should be investigated further as a potential replacement for patients with statin intolerance or as an addition for patients with statin resistance.

查看译文

关键词

3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA),cardiovascular,hyperlipidemia,low-density lipoprotein,proprotein convertase subtilsin-kixen type 9 inhibitor (PCSK9i),statin intolerance,statin resistance,statin-associated muscle symptoms (SAMS)

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要